[1]
Ohdo S. Chronopharmacology focused on biological clock. Drug Metab Pharmacokinet 2007; 22: 3-14.
[2]
Smolensky MH, Lemmer B, Reinberg AE. Chronobiology and chronotherapy of allergic rhinitis and bronchial asthma. Adv Drug Del Rev 2007; 59: 852-82.
[3]
Ohdo S. Changes in toxicity and effectiveness with timing of drug administration. Drug Safety 2003; 26: 999-1010.
[4]
Zhang Y, Zhang Z, Wu F. A novel pulsed-release system based on swelling and osmotic pumping mechanism. J Control Release 2003; 89: 47-55.
[5]
Martin R. Nocturnal asthma: An overview. In: Martin R, Ed. Nocturnal asthma: Mechanisms and treatment. Mount Kisco, New York: Futura Publishing Co., Inc 1993; pp. 71-115.
[6]
Sutherland ER, Ellison MC, Kraft M, Martin RJ. Elevated serum melatonin is associated with the nocturnal worsening of asthma. J Allergy Clin Immunol 2003; 112: 513-7.
[7]
Sawada T, Sako K, Fukui M, Yokohama S, Hayashi M. A new index, the core erosion ratio, of compression-coated timed-release tablets predicts the bioavailability of acetaminophen. Int J Pharm 2003; 265: 55-63.
[8]
Ozeki Y, Watanabe Y, Inoue S, Danjo K. Evaluation of the compression characteristics and physical properties of the newly invented one-step dry-coated tablets. Int J Pharm 2003; 267: 69-78.
[9]
Rane AB, Gattani SG, Kadam VD, Tekade AR. Formulation and evaluation of press coated tablets for pulsatile drug delivery using hydrophilic and hydrophobic polymers. Chem Pharm Bull 2009; 57: 1213-7.
[10]
Qureshi J, Amir M, Ahuja A, Baboota S, Ali J. Chronomodulated drug delivery system of salbutamol sulphate for the treatment of nocturnal asthma. Indian J Pharm Sci 2008; 70: 351-6.
[11]
Robert OC, Rupi KP, Ian WK. Novel sustained release microspheres for pulmonary drug delivery. J Control Release 2005; 104: 79-90.
[12]
Zhang Y, Zhang Z. Simple determination of terbutaline in dog plasma by column- switching liquid chromatography. J Chromatogr B 2004; 805: 211-4.
[13]
McEvoy GK. AHFS Drug Information, 2000: American Society of
Health-System Pharmacists 2000.
[14]
Gohel MC. Modulation of active pharmaceutical material release from a novel ‘tablet in capsule system’containing an effervescent blend. J Control Release 2002; 79: 157-64.
[15]
Baojian W, Ningyun S, Xiuli W, Wei W. Characterization of 5-fluorouracil release from Hydroxypropylmethylcellulose compression coated tablets. Pharm Dev Techn 2007; 12: 203-10.
[16]
Wadke DA, Serajuddin ATM. Preformulation testing Pharmaceutical dosage forms: Tablets. 2nd ed. Marcel Dekker New York 1989.
[17]
Pramodkumar T, Shivakumar H. Novel core in cup buccoadhesive systems and films of terbutalinesulphate- development and in vitro evaluation. Asian J Pharm Sci 2006; 1: 175-87.
[18]
Wilson AM. The role of antihistamines in asthma management. Treat Respir Med 2006; 5: 149-58.
[19]
Arora S, Ali J, Ahuja A, Baboota S, Qureshi J. Pulsatile drug delivery systems: An approach for controlled drug delivery. Indian J Pharm Sci 2006; 68: 295-300.
[20]
Ross AC, Macrae RJ, Walther M, Stevens HN. Chronopharmaceutical drug delivery from a pulsatile capsule device based on programmable erosion. J Pharm Pharmacol 2000; 52: 903-9.
[21]
Kumar AH, Kavitha K, Kumar SA, Kumar MR, Singh SJ. Novel approach of bilayer tablet technology- A review. Int J Pharm Chem Biol Sci 2013; 3: 887-93.
[22]
Spandana KMA, Kumar SKS, Parthiban S. Bilayer floating tablets - A review. Indian J Pharm Sci Res 2013; 3: 1-8.
[23]
Higuchi T. Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci 1963; 52: 1145-9.
[24]
Debnath M. Bilayer tableting technology: An overview. J Pharm Res 2012; 5: 310-4.
[25]
Bhandari A, Bhatt GK, Kothiyal P, Gosain S. Bilayer tablet oral solid drug delivery system and challenges in the formulation: A review. Int J Pharm Res Dev 2012; 4: 29-44.
[26]
Pujara ND, Gokani RK, Paun JS. Bilayer tablet-an emerging trend. Int J Pharm Res Dev 2012; 4: 103-4.
[27]
Kale SS, Saste VS, Ughade PL, Baviskar DT. Bilayer tablet. Int J Pharm Sci Rev Res 2011; 9: 25-30.
[28]
Reddy TP, Rao VD, Kumar KR. Bi-layer technology- an emerging trend: A review. Int J Res Dev Pharm Life Sci 2013; 2: 404-11.
[29]
Islam MS, Reza S, Rahman H. In vitro release kinetics study of diltiazem hydrochloride from wax and kollidon SR based matrix tablets. Iran J Pharm Res 2010; 7: 101-8.
[30]
Kivelä L, Papadopoulos MR, Antypa N. Chronotype and psychiatric disorders. Curr Sleep Med Rep 2018; 4(2): 94-103.
[31]
Nainwal N. Chronotherapeutics- A chronopharmaceutical approach to drug delivery in the treatment of asthma. J Control Release 2012; 163(3): 353-60.
[32]
Khan I, Ul Haq Z, Shaheen A, et al. Systematic review and meta-analysis of association of β2-adrenergic receptor gene polymorphisms with nocturnal asthma. J Postgrad Med Inst (Peshawar-Pakistan) 2017; 31: 234-42.
[33]
Singh B, Saini G, Jhanwar B. Colon specific chronotherapeutic drug delivery for nocturnal asthma: Effect of eudragit enteric coating on matrix tablets of salbutamol sulphate. Int J Pharm Tech Res 2017; 10: 19-30.
[34]
Chaudhari SP, Chaudhari PM, Narawane S. Development and optimization of chronopharmaceutical drug delivery system for asthma. J Drug Deliv Ther 2016; 6: 25-33.
[35]
Popova T, Petkova V, Dimitrov M. Formulation approaches to pulsatile-release chronotherapeutical drug delivery system with montelukast sodium. World J Pharm Pharm Sci 2016; 5: 1-17.
[36]
Rana P, Patel M, Khetani N. Pulsatile drug delivery system of
theophylline for the treatment of nocturnal asthma J Pharm S Bio-
Sci Res 2015; 5: 579-88.
[37]
Pandey S, Mehta P, Patel H, Shah R, Gupta A, Mishra A. Novel time and site specific “tablets in capsule” system for nocturnal asthma treatment. J Pharm Investig 2014; 44: 381-90.
[38]
Alavoine L, Taillé C, Ball J, et al. Nocturnal asthma: Proof-of-concept open-label study with delayed-release prednisone. Pulmonary Ther 2015; 1: 43-52.
[39]
Merikanto I, Englund A, Kronholm E, et al. Evening chronotypes have the increased odds for bronchial asthma and nocturnal asthma. Chronobiol Int 2013; 31: 95-101.
[40]
Chang DS, Venzon D, Raut S, Klosner A, Intra J, Kahler ES. Bilayer tablets of B vitamins and process for preparing the
same US20170281666A1 (2017).
[41]
Abebe A, Martin K, Patel JM, Desai D, Timmins P. Bilayer
tablet formulations US20150238421A1 (2015).
[42]
Eisenreich W. Bilayer tablet of telmisartan and amlodipine US20060110450A1 (2006).
[43]
Seob BJ, Sun CB, Su-yeon K, et al. Bilayer tablets comprising bepotastine or
its salt KR101731078B1 (2016).
[44]
Soon YC, Jong-Oh K, Wook TJ, Beom GJ, Jin KJ, Bong U. Loxoprofen oral bilayer tablet and preparation method thereof KR101750652B1 2017.
[45]
Lianming L, Qiáo H, Qiáo HY, et al. Tegafur gimeracil oteracil potassium
sustained-release bilayer tablet and preparation method
thereof CN106333933A (2016).
[46]
Hui Y, Gǎng WC. Bilayer tablet comprising metformin
hydrochloride and its preparation method net englitazone CN107432869A (2016).
[47]
Xīn CZ, Lìjié X, Fāng LX, Kǎn H, Huìqín Z. Method for
preparing telmisartan and amlodipine double-layer tablets CN106822112A 2017.
[48]
Fernández PA, Velada CJ, Kumar R, Álvarez FL. Tablets
comprising mirabegron and solifenacin WO2017186593A1 (2017).
[49]
Fēng DY, Xìngdōng Z, Yè ZR, Liàng SL. Herba dendrobii
double-layer tablet, and preparation method thereof CN107095969A (2017).
[50]
Türkyilmaz A, Pehlivan AN, Ayhan M, Demir I, Ramazanoglu G. Bilayer tablet formulations of montelukast and rupatadine WO2017182641A1 (2017).
[51]
Davar N, Ayer AD, Hwang PM, Shivanand P, Pollock BJ. Anti-asthma therapy US6224907B1 (2001).
[52]
Patel JD, Patel DT, Patel SD. Novel pulsatile drug delivery
system US20170202786A1 (2017).
[53]
Durrington HJ, Farrow SN, Ray DW. Recent advances in chronotherapy for the management of asthma. Chronophysiol Ther 2014; 4: 125-35.
61
5
1
1